105 related articles for article (PubMed ID: 25776533)
1. Verifying the markers of ovarian cancer using RNA-seq data.
Liu T; Yu N; Ding F; Wang S; Li S; Zhang X; Sun X; Chen Y; Liu P
Mol Med Rep; 2015 Jul; 12(1):1125-30. PubMed ID: 25776533
[TBL] [Abstract][Full Text] [Related]
2. Highly informative marker sets consisting of genes with low individual degree of differential expression.
Galatenko VV; Shkurnikov MY; Samatov TR; Galatenko AV; Mityakina IA; Kaprin AD; Schumacher U; Tonevitsky AG
Sci Rep; 2015 Oct; 5():14967. PubMed ID: 26446398
[TBL] [Abstract][Full Text] [Related]
3. RNA sequencing (RNA-Seq) and its application in ovarian cancer.
Wang J; Dean DC; Hornicek FJ; Shi H; Duan Z
Gynecol Oncol; 2019 Jan; 152(1):194-201. PubMed ID: 30297273
[TBL] [Abstract][Full Text] [Related]
4. Core signaling pathways in ovarian cancer stem cell revealed by integrative analysis of multi-marker genomics data.
Zhang T; Xu J; Deng S; Zhou F; Li J; Zhang L; Li L; Wang QE; Li F
PLoS One; 2018; 13(5):e0196351. PubMed ID: 29723215
[TBL] [Abstract][Full Text] [Related]
5. Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy.
Barrett CL; DeBoever C; Jepsen K; Saenz CC; Carson DA; Frazer KA
Proc Natl Acad Sci U S A; 2015 Jun; 112(23):E3050-7. PubMed ID: 26015570
[TBL] [Abstract][Full Text] [Related]
6. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
Xu G; Zhang M; Zhu H; Xu J
Gene; 2017 Mar; 604():33-40. PubMed ID: 27998790
[TBL] [Abstract][Full Text] [Related]
7. Identification of Specific Cell Subpopulations and Marker Genes in Ovarian Cancer Using Single-Cell RNA Sequencing.
Li Y; Wang J; Wang F; Gao C; Cao Y; Wang J
Biomed Res Int; 2021; 2021():1005793. PubMed ID: 34660776
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
[TBL] [Abstract][Full Text] [Related]
9. Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array.
Vathipadiekal V; Wang V; Wei W; Waldron L; Drapkin R; Gillette M; Skates S; Birrer M
Clin Cancer Res; 2015 Nov; 21(21):4960-9. PubMed ID: 25944803
[TBL] [Abstract][Full Text] [Related]
10. A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome.
Reinartz S; Finkernagel F; Adhikary T; Rohnalter V; Schumann T; Schober Y; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Müller-Brüsselbach S; Müller R
Genome Biol; 2016 May; 17(1):108. PubMed ID: 27215396
[TBL] [Abstract][Full Text] [Related]
11. Deep transcriptome profiling of ovarian cancer cells using next-generation sequencing approach.
Li L; Liu J; Yu W; Lou X; Huang B; Lin B
Methods Mol Biol; 2013; 1049():139-69. PubMed ID: 23913215
[TBL] [Abstract][Full Text] [Related]
12. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
13. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
Wu YH; Chang TH; Huang YF; Huang HD; Chou CY
Oncogene; 2014 Jun; 33(26):3432-40. PubMed ID: 23934190
[TBL] [Abstract][Full Text] [Related]
14. Independent test set performance in the prediction of early relapse in ovarian cancer with gene expression profiles.
De Smet F; Pochet NL; De Moor BL; Van Gorp T; Timmerman D; Vergote IB; Hartmann LC; Damokosh AI; Hoersch S
Clin Cancer Res; 2005 Nov; 11(21):7958-9; author reply 7959. PubMed ID: 16278422
[No Abstract] [Full Text] [Related]
15. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression.
Rangel LB; Sherman-Baust CA; Wernyj RP; Schwartz DR; Cho KR; Morin PJ
Oncogene; 2003 Oct; 22(46):7225-32. PubMed ID: 14562052
[TBL] [Abstract][Full Text] [Related]
16. Population analysis of microsatellite genotypes reveals a signature associated with ovarian cancer.
Fonville NC; Vaksman Z; McIver LJ; Garner HR
Oncotarget; 2015 May; 6(13):11407-20. PubMed ID: 25779658
[TBL] [Abstract][Full Text] [Related]
17. Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancer.
Gov E; Arga KY
Sci Rep; 2017 Jul; 7(1):4996. PubMed ID: 28694494
[TBL] [Abstract][Full Text] [Related]
18. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.
Welsh JB; Zarrinkar PP; Sapinoso LM; Kern SG; Behling CA; Monk BJ; Lockhart DJ; Burger RA; Hampton GM
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1176-81. PubMed ID: 11158614
[TBL] [Abstract][Full Text] [Related]
19. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
[TBL] [Abstract][Full Text] [Related]
20. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
